Cognitive impairment in CKD patients: a guidance document by the CONNECT network

Area of Science:

• Nephrology
• Neurology
• Cognitive Science

Background:

• Cognitive impairment is a frequent and severe complication in patients with chronic kidney disease (CKD).
• Prevalence is notably higher in CKD patients, particularly those on hemodialysis, compared to the general population.

Purpose of the Study:

• To provide comprehensive guidance on the epidemiology, risk factors, pathophysiology, diagnosis, and clinical management of cognitive impairment associated with CKD.
• To synthesize current knowledge and expert opinion for clinicians managing CKD patients.

Main Methods:

• The paper is a position paper developed by a European cooperative network.
• It reviews existing literature and expert consensus on CKD-related cognitive impairment.
• Guidance covers epidemiology, risk factors, pathophysiology, diagnostic strategies, and therapeutic interventions.

Main Results:

• CKD-related cognitive impairment stems from a complex interplay of factors including uremic toxins, anemia, vascular damage, metabolic issues, and comorbidities like diabetes and hypertension.
• Early identification is crucial, utilizing cognitive tests, neuroimaging, and biomarkers.
• Management involves pharmacological and non-pharmacological approaches, focusing on medication review and tailored interventions.

Conclusions:

• Addressing cognitive impairment in CKD patients is vital for improving outcomes.
• Early detection, careful medication management, and individualized therapeutic strategies are key.
• This guidance aims to enhance patient care by highlighting the importance of managing cognitive decline in CKD.